299 related articles for article (PubMed ID: 7342384)
1. Optimal age for vaccinating Nigerian children against measles. I. Neonatal antibody profile and subsequent susceptibility to measles.
Harry TO; Ogunmekan DA
Trop Geogr Med; 1981 Dec; 33(4):375-8. PubMed ID: 7342384
[TBL] [Abstract][Full Text] [Related]
2. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
Ogunmekan DA; Harry TO
Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
[TBL] [Abstract][Full Text] [Related]
3. Measles HI-antibody levels in Lagos children, Nigeria: a follow-up study to resurgence of measles in Lagos metropolis.
Oyefolu AO; Omilabu SA
West Afr J Med; 2001; 20(3):238-42. PubMed ID: 11922159
[TBL] [Abstract][Full Text] [Related]
4. Measles antibody levels from birth to 9 months of age in Nigerian infants.
Abdurrahman MB; Greenwood BM; Olafimihan O; Whitle HC
Afr J Med Med Sci; 1982 Sep; 11(3):113-5. PubMed ID: 6307026
[TBL] [Abstract][Full Text] [Related]
5. Elimination of maternal antibodies against measles (is the policy of vaccinating children younger than nine months of age suitable for Turkey?).
Kanra G; Ceyhan M
Turk J Pediatr; 1991; 33(4):217-20. PubMed ID: 1814038
[TBL] [Abstract][Full Text] [Related]
6. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
[TBL] [Abstract][Full Text] [Related]
7. Passive immunity to measles in the breastmilk and cord blood of some nigerian subjects.
Oyedele OO; Odemuyiwa SO; Ammerlaan W; Muller CP; Adu FD
J Trop Pediatr; 2005 Feb; 51(1):45-8. PubMed ID: 15601649
[TBL] [Abstract][Full Text] [Related]
8. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.
Arpadi SM; Markowitz LE; Baughman AL; Shah K; Adam H; Wiznia A; Lambert G; Dobroszycki J; Heath JL; Bellini WJ
Pediatrics; 1996 May; 97(5):653-7. PubMed ID: 8628602
[TBL] [Abstract][Full Text] [Related]
9. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].
Hohendahl J; Peters N; Hüttermann U; Rieger C
Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702
[TBL] [Abstract][Full Text] [Related]
10. [Loss of maternal measles antibodies acquired by vaccination against measles].
Strauss J; Mrázová M; Macátová I; Beranová I
Cesk Epidemiol Mikrobiol Imunol; 1991 May; 40(3):137-43. PubMed ID: 1828716
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of vaccination against measles at nine months of age (report of an epidemic).
Ceyhan M; Kanra G; Vargel S; Işikçelik Y
Turk J Pediatr; 1992; 34(3):127-33. PubMed ID: 1485379
[TBL] [Abstract][Full Text] [Related]
12. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
[TBL] [Abstract][Full Text] [Related]
13. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team.
Markowitz LE; Albrecht P; Rhodes P; Demonteverde R; Swint E; Maes EF; Powell C; Patriarca PA
Pediatrics; 1996 Jan; 97(1):53-8. PubMed ID: 8545224
[TBL] [Abstract][Full Text] [Related]
14. [Age-related loss of maternal antibodies against measles in children in La Plata].
del Buono MB; Vaschetti P; Iannicelli J; Silber R
Rev Argent Microbiol; 2003; 35(2):102-5. PubMed ID: 12920993
[TBL] [Abstract][Full Text] [Related]
15. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
16. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Collaborative study by the Ministry of Health of Kenya and the World Health Organization.
Bull World Health Organ; 1977; 55(1):21-31. PubMed ID: 302153
[TBL] [Abstract][Full Text] [Related]
17. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of placentally transmitted antibodies for measles in infants 3 to 11 months old in an urban slum community.
Deivanayagam N; Vasudevan S; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
Indian Pediatr; 1990 Sep; 27(9):919-23. PubMed ID: 2286435
[TBL] [Abstract][Full Text] [Related]
19. Age of measles immunization in tropics.
Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
[TBL] [Abstract][Full Text] [Related]
20. Low antibody response in infants with measles and children with subclinical measles virus infection.
Cherian T; Joseph A; John TJ
J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
